Shariftabrizi A[au] - Search Results

Year	Number of Results
2003	1
2005	4
2006	4
2007	5
2008	3
2011	2
2012	4
2013	4
2014	7
2015	6
2016	5
2017	5
2018	3
2019	4
2021	2
2022	0

1

Multifocal Meningiomas Mimicking Metastasis on 18F-Fluciclovine PET/CT.

Aldine AS, Balaawi K, Saadeddin A, Shariftabrizi A, Kandemirl S. Aldine AS, et al. Among authors: shariftabrizi a. Nucl Med Mol Imaging. 2021 Oct;55(5):261-264. doi: 10.1007/s13139-021-00715-5. Epub 2021 Sep 23. Nucl Med Mol Imaging. 2021. PMID: 34721720

2

Cancer stem cell research in Iran: potentials and challenges.

Roudi R, Ebrahimi M, Shariftabrizi A, Madjd Z. Roudi R, et al. Among authors: shariftabrizi a. Future Oncol. 2017 Aug;13(20):1809-1826. doi: 10.2217/fon-2017-0091. Epub 2017 Aug 4. Future Oncol. 2017. PMID: 28776391 Review.

3

18F-Fluciclovine-Avid Mediastinal Lymph Node Metastasis of Cutaneous Malignant Melanoma.

Shariftabrizi A, Pillenahalli Maheshwarappa R, Kahn D, Pollard J. Shariftabrizi A, et al. Clin Nucl Med. 2021 Feb 1;46(2):e97-e99. doi: 10.1097/RLU.0000000000003319. Clin Nucl Med. 2021. PMID: 33031240

4

Recent Advancements in Prognostic Factors of Epithelial Ovarian Carcinoma.

Ezzati M, Abdullah A, Shariftabrizi A, Hou J, Kopf M, Stedman JK, Samuelson R, Shahabi S. Ezzati M, et al. Among authors: shariftabrizi a. Int Sch Res Notices. 2014 Oct 29;2014:953509. doi: 10.1155/2014/953509. eCollection 2014. Int Sch Res Notices. 2014. PMID: 27382614 Free PMC article. Review.

5

Expression of CD133 cancer stem cell marker in melanoma: a systematic review and meta-analysis.

Madjd Z, Erfani E, Gheytanchi E, Moradi-Lakeh M, Shariftabrizi A, Asadi-Lari M. Madjd Z, et al. Among authors: shariftabrizi a. Int J Biol Markers. 2016 May 28;31(2):e118-25. doi: 10.5301/jbm.5000209. Int J Biol Markers. 2016. PMID: 27102864 Free article. Review.

6

High GD2 expression defines breast cancer cells with enhanced invasiveness.

Mansoori M, Roudi R, Abbasi A, Abolhasani M, Abdi Rad I, Shariftabrizi A, Madjd Z. Mansoori M, et al. Among authors: shariftabrizi a. Exp Mol Pathol. 2019 Aug;109:25-35. doi: 10.1016/j.yexmp.2019.05.001. Epub 2019 May 8. Exp Mol Pathol. 2019. PMID: 31075227

7

MicroRNA-31 inhibits RhoA-mediated tumor invasion and chemotherapy resistance in MKN-45 gastric adenocarcinoma cells.

Korourian A, Roudi R, Shariftabrizi A, Madjd Z. Korourian A, et al. Among authors: shariftabrizi a. Exp Biol Med (Maywood). 2017 Dec;242(18):1842-1847. doi: 10.1177/1535370217728460. Epub 2017 Aug 24. Exp Biol Med (Maywood). 2017. PMID: 28836853 Free PMC article.

8

Evaluation of a novel biocompatible magnetic nanomedicine based on beta-cyclodextrin, loaded doxorubicin-curcumin for overcoming chemoresistance in breast cancer.

Rastegar R, Akbari Javar H, Khoobi M, Dehghan Kelishadi P, Hossein Yousefi G, Doosti M, Hossien Ghahremani M, Shariftabrizi A, Imanparast F, Gholibeglu E, Gholami M. Rastegar R, et al. Among authors: shariftabrizi a. Artif Cells Nanomed Biotechnol. 2018;46(sup2):207-216. doi: 10.1080/21691401.2018.1453829. Epub 2018 Apr 24. Artif Cells Nanomed Biotechnol. 2018. PMID: 29688063

9

Common molecular markers between circulating tumor cells and blood exosomes in colorectal cancer: a systematic and analytical review.

Vafaei S, Fattahi F, Ebrahimi M, Janani L, Shariftabrizi A, Madjd Z. Vafaei S, et al. Among authors: shariftabrizi a. Cancer Manag Res. 2019 Sep 25;11:8669-8698. doi: 10.2147/CMAR.S219699. eCollection 2019. Cancer Manag Res. 2019. PMID: 31576171 Free PMC article.

10

Positive stone culture is associated with a higher rate of sepsis after endourological procedures.

Eswara JR, Shariftabrizi A, Sacco D. Eswara JR, et al. Among authors: shariftabrizi a. Urolithiasis. 2013 Oct;41(5):411-4. doi: 10.1007/s00240-013-0581-8. Epub 2013 Jun 13. Urolithiasis. 2013. PMID: 23760449

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results